TriSalus Life Sciences (TLSI) Capital Expenditures (2022 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Capital Expenditures of $141000.0 for Q1 2026, up 62.07% year-over-year from $87000.0 in Q1 2025, and up 117.43% quarter-over-quarter from -$809000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) Capital Expenditures (2022 - 2026) Analysis & Trends
TriSalus Life Sciences' Capital Expenditures history runs 5 years deep, the most recent figure standing at $141000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures rose 62.07% year-over-year to $141000.0; the TTM figure through Mar 2026 stood at $122000.0 (up 480.95% YoY), while the FY2025 annual figure was $68000.0, changed N/A from the prior year.
- Capital Expenditures for Q1 2026 stood at $141000.0, up from -$809000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $857000.0 in Q3 2025, with the low at -$809000.0 in Q4 2025.
- The 5-year median for Capital Expenditures is $63000.0 (2024), against an average of $25571.4.
- The sharpest annual moves came in 2024 and 2025: Capital Expenditures surged 842.86% in 2024, then sank 211.67% in 2025.
- TriSalus Life Sciences' Capital Expenditures stood at -$439000.0 in 2022, then jumped by 184.74% to $372000.0 in 2023, then sank by 179.3% to -$295000.0 in 2024, then plunged by 174.24% to -$809000.0 in 2025, then surged by 117.43% to $141000.0 in 2026.
- Business Quant data shows TLSI's Capital Expenditures at $141000.0 in Q1 2026, -$809000.0 in Q4 2025, and $857000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 87.50 Mn |
| 10 | TriSalus Life Sciences | 306.64 Mn | 260.35 Mn | 9.90 Mn | 82,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 82,000.00 |
| Jun 30, 2026 | 82,000.00 |
| Mar 31, 2026 | 141,000.00 |
| Mar 31, 2026 | 141,000.00 |
| Dec 31, 2025 | -809,000.00 |
| Dec 31, 2025 | -809,000.00 |
| Sep 30, 2025 | 857,000.00 |
| Sep 30, 2025 | 857,000.00 |
| Jun 30, 2025 | -67,000.00 |
| Jun 30, 2025 | -67,000.00 |
| Mar 31, 2025 | 87,000.00 |
| Mar 31, 2025 | 87,000.00 |
| Dec 31, 2024 | -295,000.00 |
| Dec 31, 2024 | -295,000.00 |
| Sep 30, 2024 | 169,000.00 |
| Sep 30, 2024 | 169,000.00 |
| Jun 30, 2024 | 60,000.00 |
| Jun 30, 2024 | 60,000.00 |
| Mar 31, 2024 | 66,000.00 |
| Mar 31, 2024 | 66,000.00 |